Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer
Authors
Keywords
-
Journal
BRIEFINGS IN BIOINFORMATICS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-03-09
DOI
10.1093/bib/bbaa047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15
- (2019) Yu Ying Liu et al. CELL BIOLOGY INTERNATIONAL
- B cell–intrinsic requirement for STK4 in humoral immunity in mice and human subjects
- (2019) Imogen Moran et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Suppression of long non‐coding RNA TNRC6C‐AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway
- (2019) Liu‐Xue Yang et al. CELL PROLIFERATION
- Functional analysis of lncRNAs based on competitive endogenous RNA in tongue squamous cell carcinoma
- (2019) Yidan Song et al. PeerJ
- Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis
- (2019) Qiaofen Fu et al. OncoImmunology
- Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients
- (2019) Michael J. Duffy et al. CLINICAL CHEMISTRY
- Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes
- (2019) Wade T. Iams et al. Journal of Thoracic Oncology
- Immunosuppressive B cells expressing PD-1/PD-L1 in solid tumors: A mini review
- (2019) Xiaowen Sun et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
- (2019) Erica di Martino et al. Scientific Reports
- B Cells as an Immune-Regulatory Signature in Ovarian Cancer
- (2019) Gupta et al. Cancers
- Silencing long noncoding RNA OGFRP1 inhibits the proliferation and migration of cervical carcinoma cells
- (2019) Kun Zou et al. CELL BIOCHEMISTRY AND FUNCTION
- LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis
- (2019) Yuan Sui et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tumor Dormancy and Interplay with Hypoxic Tumor Microenvironment
- (2019) Elena Butturini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers
- (2019) Rui Li et al. Journal of Translational Medicine
- Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens
- (2019) Sara Wahlin et al. OncoImmunology
- Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer
- (2019) Siqi Bao et al. BRIEFINGS IN BIOINFORMATICS
- A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma
- (2019) Muhammad Shaban et al. Scientific Reports
- Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells
- (2019) Kamila Hladíková et al. Journal for ImmunoTherapy of Cancer
- LncRNA PART1 modulates toll-like receptor pathways to influence cell proliferation and apoptosis in prostate cancer cells
- (2018) Ming Sun et al. BIOLOGICAL CHEMISTRY
- Quantifying tumor-infiltrating immune cells from transcriptomics data
- (2018) Francesca Finotello et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Integrative genome-wide analysis of long noncoding RNAs in diverse immune cell types of melanoma patients
- (2018) Lei Wang et al. CANCER RESEARCH
- Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
- (2018) Si-si Wang et al. Cellular & Molecular Immunology
- Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
- (2018) Diana Miao et al. SCIENCE
- Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy
- (2018) Frederick S. Varn et al. OncoImmunology
- A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapy
- (2018) Frederick S. Varn et al. OncoImmunology
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Clinical significance of tumor-infiltrating lymphocytes in breast cancer
- (2016) Sasha E. Stanton et al. Journal for ImmunoTherapy of Cancer
- B cell regulation of the anti-tumor response and role in carcinogenesis
- (2016) Marc Schwartz et al. Journal for ImmunoTherapy of Cancer
- Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials
- (2015) M. V. Dieci et al. ANNALS OF ONCOLOGY
- The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies
- (2015) Julie Earl et al. BMC GENOMICS
- The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4
- (2015) Valeria Ranzani et al. NATURE IMMUNOLOGY
- Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals
- (2015) Zhenyu Ou et al. Oncotarget
- Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals
- (2015) Qun Rao et al. Oncotarget
- In Vivo Disruption of an Rb-E2F-Ezh2 Signaling Loop Causes Bladder Cancer
- (2014) M. Santos et al. CANCER RESEARCH
- Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
- (2014) M. D. Iglesia et al. CLINICAL CANCER RESEARCH
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation
- (2013) Gangqing Hu et al. NATURE IMMUNOLOGY
- Long non-coding RNAs: new players in cell differentiation and development
- (2013) Alessandro Fatica et al. NATURE REVIEWS GENETICS
- Genome Regulation by Long Noncoding RNAs
- (2012) John L. Rinn et al. Annual Review of Biochemistry
- Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer
- (2012) Markus Riester et al. CLINICAL CANCER RESEARCH
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Association of mast cells with microvessel density in urothelial carcinomas of the urinary bladder
- (2011) Aysegul Sari et al. Annals of Diagnostic Pathology
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More